The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
estradiol hemihydrate, trenbolone acetate and tylosin tartrate
estradiol hemihydrate, trenbolone acetate and tylosin tartrate · ESTRADIOL HEMIHYDRATE 14 mg/1; TRENBOLONE ACETATE 140 mg/1; TYLOSIN TARTRATE 29 mg/1 · Implant · Elanco US Inc.
NDC 58198-1001-01 · 5 POUCH in 1 CARTON / 1 CARTRIDGE in 1 POUCH / 20 IMPLANT in 1 CARTRIDGE · EXPORT ONLY · View full market →
Medicare Part D
This product is labeled for export only and is not sold to US patients, so Medicare does not price it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of estradiol hemihydrate, trenbolone acetate and tylosin tartrate (Implant)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Elanco US Inc. | ESTRADIOL HEMIHYDRATE 14 mg/1; TRENBOLONE ACETATE 140 mg/1; TYLOSIN TARTRATE 29 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "estradiol hemihydrate, trenbolone acetate and tylosin tartrate — NDC 58198-1001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/58198100101.
Free to cite with attribution — see how the data is put together.